Some questions about preadmission metformin use and mortality in patients with sepsis and diabetes mellitus
Main Authors: | Jiarong Ye, Qianrong Liang, Xiaotu Xi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | Critical Care |
Online Access: | http://link.springer.com/article/10.1186/s13054-019-2392-y |
Similar Items
-
Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies
by: Huoyan Liang, et al.
Published: (2019-02-01) -
NT-proBNP levels might predict outcomes in severe sepsis, but renal function cannot be ignored
by: Jiarong Ye, et al.
Published: (2019-11-01) -
Association Between Preadmission Metformin Use and Outcomes in Intensive Care Unit Patients With Sepsis and Type 2 Diabetes: A Cohort Study
by: Qilin Yang, et al.
Published: (2021-03-01) -
Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study
by: Rene A. Posma, et al.
Published: (2020-03-01) -
Effectiveness outcomes of preadmission testing for presurgical patients
by: Home, Elfriede
Published: (2010)